Ropes & Gray acted as counsel to Athyrium Capital Management in the formation of its $2 billion healthcare fund, Athyrium Opportunities Fund III. The closing of the fund was announced on Dec. 4, with approximately $2.025 billion from a global investor base comprises more than 45 institutions, including public and private pension funds, endowments, foundations and sovereign wealth funds.
Athyrium Capital Management, LP ("Athyrium Capital") is a specialized asset management company formed in 2008 to focus on investment opportunities in the global healthcare sector. Athyrium Capital manages funds with committed capital in excess of $3.7 billion.
Athyrium Opportunities Fund III seeks to make investments of $20 million to $300 million in commercial-stage healthcare companies in North America, Europe, Asia and Australia. The Fund invests across the healthcare sector including pharmaceuticals, medical products, diagnostics, healthcare services and healthcare information technology.
The Ropes & Gray team was led by hedge funds partner Jessica O’Mary and included tax partner Adam Greenwood and corporate associate Christian Vareika.
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.